Publication | Closed Access

NecroX-5 alleviate lipopolysaccharide-induced acute respiratory distress syndrome by inhibiting TXNIP/NLRP3 and NF-κB

InflammationAcute Lung InjuryAnti-inflammatoryRespiratory Distress Syndrome (Pulmonary Critical Care)MedicineRespiratory ToxicologyChronic InflammationCell DeathSepsisRespiratory Distress Syndrome (Neonatal Medicine)PharmacologyInflammatory DiseaseOxidative Stress